|
|
|
|
|
|
by mise_en_place
1216 days ago
|
|
|
I feel like you're splitting hairs. The intended purpose of GLP-1 drugs is to improve A1C in existing diabetic patients. Weight loss is directly correlated with that, because if your body is properly expending glucose, then the excess will not be stored as fat, or sit around in your blood stream in the case of diabetics. |
|
|
GLP-1 RA does NOT achieve a reduced A1c through weight loss. It achieves improved glycemic control by slowing the release of glucose into the blood as well as promoting increased production of insulin in response to glucose. The overall result is a reduction in blood glucose.
A1c is a measure of your glycemic health that spans around 90 days with heavier weight on more recent trends. It's like a longer blood glucose average measurement. There are actually algorithms that can calculate an estimate of your A1c based on blood glucose trends, which is referred to GMI (glucose management indicator).
The gastric effects leading to feeling full sooner and longer are a side effect and is what leads to weight loss. It also fades with time. Having been on various GLP-1 RAs over a decade, they don't provide this benefit to me anymore. Even with Mounjaro also being a GIP, it's just doing its primary job for me.